OMRON Healthcare Surpasses 50 Million Nebulizers Sold

Kyoto, Japan – (October 31, 2025) – OMRON Healthcare Co., Ltd., a global leader in the field of clinically proven, innovative medical equipment for home health monitoring and treatment, today announced that cumulative sales of its nebulizers have surpassed 50 million units. This proud milestone underscores the company’s long-standing commitment to helping people around the world to live healthier lives through management of respiratory conditions. 

Internationally, respiratory diseases are a growing issue, particularly in emerging economies. According to the World Health Organization, some 339 million people suffer from asthma worldwide, with an estimated 3.5 million deaths each year due to Chronic Obstructive Pulmonary Disorder (COPD). Nebulizers, which convert liquid medications into a fine mist that can be inhaled directly into the lungs, are a key tool for easing the burden of respiratory diseases in children and adults alike.  

Almost five decades as a trusted partner in respiratory therapy  

Since the launch of its first nebulizer in 1978, OMRON Healthcare has pioneered the development of compact home-use devices that deliver medical-grade respiratory treatment outside of clinical settings, prioritizing ease of use for families and patients of all ages, from young children to older adults.   

Design landmarks ranging from the first ultrasonic models to portable mesh-type and low-noise compressor technologies have made medication delivery more consistent and convenient for millions of users worldwide, including those living with chronic and acute respiratory ailments such as asthma, COPD, RSV bronchitis, cystic fibrosis, and a range of physical disabilities. 

“Respiratory illness, such as asthma and COPD, remains one of the world’s most serious yet under-addressed health challenges,” said Tomohiro Kukita, Senior Manager, Product Planning Strategy HQ of OMRON Healthcare Co., Ltd. “Our goal has always been to reduce that burden—for children, adults, and caregivers—through technology that empowers people to breathe easier and live better. Meanwhile our global footprint ensures reliable access to quality respiratory treatment in both developed and emerging markets, including those where environmental pollution is a major driver of respiratory issues. Device is tailored to the specific needs of individual countries and regions, such as a new nebulizer developed for the Indian market“ 

About OMRON Healthcare 

Committed to advancing health and empowering people worldwide to live life to the fullest, OMRON Healthcare is a global leader in the field of clinically proven, innovative medical equipment for home health monitoring and treatment. Aiming to realize its vision, “Going for ZERO, Preventive Care for the Health of Society,” the company develops products for cardiovascular condition management, respiratory care, and pain therapy. Building on this, it has introduced a new digital health ecosystem that bridges patients and healthcare professionals, helping to reduce cerebro-cardiovascular events, the worsening of respiratory diseases, and limitations caused by chronic pain. 

With over 400 million units sold globally, OMRON provides the world's most recommended blood pressure monitors by healthcare professionals. Throughout its history, OMRON Healthcare has striven to improve lives and contribute to a better society by developing innovations that help people prevent, treat, and manage their medical conditions, providing products and services in over 130 countries. 

For more information, please visit:  

Website: https://healthcare.omron.com/    

LinkedIn: https://www.linkedin.com/company/omron-healthcare-co-ltd-/     

Media enquiries 

This press release is disseminated by Kyodo PR on behalf of OMRON Healthcare. For more information or for interview opportunities, please contact: 

OMRON Healthcare Press Desk: omronhealthcare-pr@kyodo-pr.co.jp